New results help predict treatment response in colorectal cancer
Tuesday, September 16, 2008 - 12:43
in Health & Medicine
Genetic testing can identify a group of patients with advanced colorectal cancer who are likely to survive on average twice as long if treated with the drug cetuximab, late breaking results show.
Read the whole article on Physorg
More from Physorg
Related
- New results help predict treatment response in colorectal cancerTue, 16 Sep 2008, 10:17:53 EDT
- Cost-effectiveness of cetuximab in metastatic colorectal cancerFri, 7 Aug 2009, 17:30:34 EDT
- Increase in P53 mutation linked to advanced colorectal cancer in blacksWed, 1 Apr 2009, 0:40:35 EDT
- New treatments offer better survival and fresh challenges in colorectal cancerFri, 21 Aug 2009, 11:58:23 EDT
- Advances in liver surgery enable the prospect of curative treatment for more patientsMon, 15 Jun 2009, 10:08:54 EDT